Sponsors (18)
The bill creates federal safety oversight and clearer labeling and standards that improve consumer protection and regulatory certainty for producers, but it raises compliance costs, may slow some product introductions, and increases regulatory administrative burdens.
Consumers will receive clearer, stronger federal safety oversight for cell‑cultivated protein products — FDA and USDA share inspection and safety roles, include premarket consultation and cGMP requirements, and will inspect under meat/poultry statutes, reducing contamination and safety risk.
Producers (including small businesses) gain regulatory clarity and consistent rules — USDA/FDA role assignments and a requirement for common standards of identity within 180 days create a predictable pathway that can speed commercialization.
Consumers get clearer labeling that distinguishes cell‑cultivated and plant‑based products from conventional meat/poultry, reducing confusion at purchase.
Small producers and manufacturers face new compliance costs — expenses from premarket reviews, cell‑bank and facility requirements, inspections, and labeling could raise costs and squeeze smaller firms.
Consumers and some producers may see delayed market entry — tighter oversight and longer premarket processes could slow product launches and limit consumer choice in the short term.
Labeling requirements (e.g., required 'not derived from' disclaimers) may stigmatize alternative proteins and reduce consumer acceptance, harming market competition for those products.
Based on analysis of 3 sections of legislative text.
Defines and requires labeling for cell‑cultivated meat/poultry and plant‑based alternative protein products and assigns agency oversight and inspection parity.
Official title: To amend the Federal Meat Inspection Act and the Poultry Products Inspection Act to ensure that consumers can make informed decisions in choosing between meat and poultry products and cell-cultivated protein products, and for other purposes.
Introduced April 30, 2026 by Mark Alford · Last progress April 30, 2026
Requires new definitions, labeling rules, and inspection parity for cell‑cultivated meat and poultry and for plant‑based alternative protein products, and directs USDA and HHS/FDA to update their formal agreement and oversight responsibilities. The bill compels agencies to revise an existing MOU within 90 days, assigns implementation and premarket/inspection duties, and requires USDA (with HHS consultation) to develop common standards of identity within 180 days.